ATRICURE INC's ticker is ATRC and the CUSIP is 04963C209. A total of 70 filers reported holding ATRICURE INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $454,000 | +38.0% | 18,707 | +8.8% | 0.00% | – |
| Q1 2017 | $329,000 | -95.9% | 17,197 | -96.6% | 0.00% | -100.0% |
| Q3 2016 | $7,981,000 | +35.7% | 504,519 | +21.2% | 0.00% | +33.3% |
| Q2 2016 | $5,883,000 | +55.2% | 416,353 | +84.9% | 0.00% | +50.0% |
| Q1 2016 | $3,791,000 | -24.0% | 225,199 | +1.2% | 0.00% | -33.3% |
| Q4 2015 | $4,991,000 | +1.7% | 222,435 | -0.7% | 0.00% | 0.0% |
| Q3 2015 | $4,907,000 | -99.9% | 223,929 | -36.0% | 0.00% | -25.0% |
| Q2 2015 | $8,626,932,000 | -17.4% | 350,119 | -31.3% | 0.00% | -20.0% |
| Q1 2015 | $10,446,601,000 | +3.7% | 509,839 | +1.0% | 0.01% | 0.0% |
| Q4 2014 | $10,071,656,000 | +372786.2% | 504,592 | +175.0% | 0.01% | +400.0% |
| Q3 2014 | $2,701,000 | -21.1% | 183,494 | -1.5% | 0.00% | -50.0% |
| Q2 2014 | $3,423,000 | -99.9% | 186,218 | +4.8% | 0.00% | 0.0% |
| Q1 2014 | $3,341,220,000 | -19.5% | 177,630 | -20.1% | 0.00% | 0.0% |
| Q4 2013 | $4,152,751,000 | +77.1% | 222,310 | +4.1% | 0.00% | +100.0% |
| Q3 2013 | $2,345,108,000 | +33.6% | 213,580 | +15.6% | 0.00% | 0.0% |
| Q2 2013 | $1,755,505,000 | – | 184,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 350,000 | $13,965,000 | 4.30% |
| SECTORAL ASSET MANAGEMENT INC | 708,717 | $28,278,000 | 2.43% |
| First Light Asset Management, LLC | 561,018 | $22,385,000 | 2.29% |
| DAFNA Capital Management LLC | 133,229 | $5,316,000 | 1.73% |
| PERKINS CAPITAL MANAGEMENT INC | 44,350 | $1,770,000 | 1.63% |
| PURA VIDA INVESTMENTS, LLC | 645,003 | $25,736,000 | 1.33% |
| Acuitas Investments, LLC | 46,353 | $1,849,000 | 1.30% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 477,064 | $19,035,000 | 0.84% |
| EMERALD ADVISERS, LLC | 500,848 | $19,984,000 | 0.82% |
| Orbimed Advisors | 1,228,189 | $49,005,000 | 0.62% |